ENHERTU subst sèche 100 mg flac
7680679670013
CH-67967
L01FD04
07.16.1.
Reimbursement limitations:
ENHERTU.0102
Cancer du sein HER2 positif
Enhertu en monothérapie est indiqué dans le traitement des patients …
1 / 3
google
Details
- Product number
- 6796701
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- Praeparatio cryodesiccata: trastuzumabum deruxtecanum 100 mg, saccharum, histidinum, histidini hydrochloridum monohydricum, polysorbatum 80, pro vitro.
Articles (1)
Enhertu 100 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
PRC
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 1704.15
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/11/2023
Authorization holder
Daiichi Sankyo (Schweiz) AG
8048 Zürich
Authorization information
- Swissmedic authorization number
- 67967
- Drug name
- Enhertu, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- PULPI
- ATC Code
- L01FD04
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 29/11/2021
- Authorization expiration date
- 30/06/2027
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ENHERTU subst sèche 100 mg flac
- Description (DE)
- ENHERTU Trockensub 100 mg Durchstf
- Market launch
- 29/11/2021
- Narcotic (BTM)
- No